Lincomycin (CAS 154-21-2)

Lincomycin is a naturally occurring lincosamide antibiotic, which has been extensively studied for its unique chemical structure and biochemical properties. Extracted originally from the bacterium Streptomyces lincolnensis, lincomycin features an unusual amino sugar and a thioether linkage, which are central to its mode of action. The primary mechanism through which lincomycin acts involves binding to the 50S subunit of bacterial ribosomes. This binding interferes with the peptidyl transferase reaction, a crucial step in protein synthesis. By doing so, lincomycin disrupts the elongation phase of protein synthesis, effectively halting bacterial growth. This specific inhibition makes it a valuable tool for studying protein synthesis in prokaryotic organisms and for exploring the molecular dynamics of ribosome function. In scientific research, lincomycin has been employed in various studies to understand the resistance mechanisms in bacteria. It serves as a basis for investigating how mutations in the ribosomal binding site can confer resistance to lincosamide antibiotics. Additionally, studies involving lincomycin have helped explain the pathway of lincosamide biosynthesis, which involves complex enzymatic reactions that are of interest in the field of natural product chemistry and enzymology.